NZ217592A - Cardioplegia-inducing pharmaceutical composition containing potassium ions facilitated by adenosine - Google Patents

Cardioplegia-inducing pharmaceutical composition containing potassium ions facilitated by adenosine

Info

Publication number
NZ217592A
NZ217592A NZ217592A NZ21759286A NZ217592A NZ 217592 A NZ217592 A NZ 217592A NZ 217592 A NZ217592 A NZ 217592A NZ 21759286 A NZ21759286 A NZ 21759286A NZ 217592 A NZ217592 A NZ 217592A
Authority
NZ
New Zealand
Prior art keywords
adenosine
cardioplegia
pharmaceutical composition
composition containing
potassium ions
Prior art date
Application number
NZ217592A
Other languages
English (en)
Inventor
Alf Sollevi
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25116698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ217592(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of NZ217592A publication Critical patent/NZ217592A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NZ217592A 1985-09-24 1986-09-16 Cardioplegia-inducing pharmaceutical composition containing potassium ions facilitated by adenosine NZ217592A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77951685A 1985-09-24 1985-09-24

Publications (1)

Publication Number Publication Date
NZ217592A true NZ217592A (en) 1990-10-26

Family

ID=25116698

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ217592A NZ217592A (en) 1985-09-24 1986-09-16 Cardioplegia-inducing pharmaceutical composition containing potassium ions facilitated by adenosine

Country Status (9)

Country Link
EP (2) EP0275249B2 (https=)
JP (1) JP2535504B2 (https=)
AT (2) ATE176154T1 (https=)
AU (1) AU613304B2 (https=)
CA (1) CA1301652C (https=)
DE (4) DE19975044I2 (https=)
DK (1) DK253187D0 (https=)
NZ (1) NZ217592A (https=)
WO (1) WO1987001593A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2930589B2 (ja) * 1986-10-06 1999-08-03 ザ ユニバーシィティ オブ バージニア アルミニ パテンツ ファンデーション 外科手術中における改善された心臓保護のためのアデノシン,ヒポキサンチン及びリボース含有溶液の使用
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
US6004945A (en) * 1990-05-10 1999-12-21 Fukunaga; Atsuo F. Use of adenosine compounds to relieve pain
US5256398A (en) * 1990-11-08 1993-10-26 Whitby Research, Inc. Composition for determining viability of tissue
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
ES2909788T3 (es) 2010-10-15 2022-05-10 Seastar Medical Inc Cartucho de citaféresis y uso del mismo
JP5729660B2 (ja) * 2011-11-21 2015-06-03 株式会社ディナーヴ 腎動脈アブレーション用のカテーテルおよびシステム
EP2802367A4 (en) 2012-01-09 2015-12-16 H David Humes CARTRIDGE AND METHOD FOR INCREASING THE HEART MUSCULAR FUNCTION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845205A (en) * 1970-06-04 1974-10-29 Univ Sydney 2-loweralkylthioadenosines
FR2129833B1 (https=) * 1971-03-16 1974-08-02 Cerm Cent Europ Rech Mauvernay
ZA7468B (en) * 1973-01-16 1974-11-27 J Voorhees Compositions and treatment of proliferatave skin diseases with phosphodiesterase inhibitors
DE3133925A1 (de) * 1981-08-27 1983-03-17 A. Nattermann & Cie GmbH, 5000 Köln Arzneimittel zur behandlung von hypertonie
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten

Also Published As

Publication number Publication date
WO1987001593A1 (en) 1987-03-26
DE3586993T3 (de) 1998-03-19
JP2535504B2 (ja) 1996-09-18
DE3590855T1 (https=) 1988-08-25
ATE84419T1 (de) 1993-01-15
EP0506205B1 (en) 1999-01-27
DE3588205T2 (de) 1999-06-02
DE3586993D1 (de) 1993-02-25
ATE176154T1 (de) 1999-02-15
EP0506205A1 (en) 1992-09-30
DK253187A (da) 1987-05-19
EP0275249B1 (en) 1993-01-13
DE3586993T2 (de) 1993-04-29
DK253187D0 (da) 1987-05-19
AU5065585A (en) 1987-04-07
DE19975044I2 (de) 2006-02-02
JPS63501497A (ja) 1988-06-09
AU613304B2 (en) 1991-08-01
EP0275249A1 (en) 1988-07-27
CA1301652C (en) 1992-05-26
EP0275249B2 (en) 1997-12-17
DE3588205D1 (de) 1999-03-11

Similar Documents

Publication Publication Date Title
EP0151989A3 (en) Means for the treatment of cardiac diseases
DE352477T1 (de) Antikrebswirkungen in einem organismus, durch erhoehen der blut- und plasmawerte von adenosin-5'-triphosphat (atp).
IT8203369A0 (it) Elettrostimolatore cardiaco impiantabile,di tipo fisiologico, in cui la frequenza di stimolazione e'regolata dalla frequenza respiratoria del paziente
AU1285592A (en) Methods for increasing extracellular adenosine and for stabilizing mast cells
IT1154319B (it) Analizzatore di anidride carbonica nel flusso espiratorio finale per determinare la pressione parziale dell'anidride carbonica nel sangue arterioso di un paziente
NO883204L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperazinyl-derivater av puriner og isosterer derav.
BG60261B2 (en) Lon-acting formulation of cefaclor
ATE223176T1 (de) Herzschrittmacher mit elektrode und integriertem sauerstoff-fühler
SE8400851L (sv) Farmaceutisk komposition med metabolisk och energetisk aktivitet till anvendning for terapeutisk behandling av hjert- och kerlsjukdomar
NZ217592A (en) Cardioplegia-inducing pharmaceutical composition containing potassium ions facilitated by adenosine
GB1499035A (en) Antistaphylococcus human immune globulin and method of preparing same
EP0226085A3 (en) Cardio pulmonary system intended for oxygenation of a patient's blood
NO882853D0 (no) Korreksjon med dobbeltraadet rna av unormale tilstander i immunkomplekser som er i omloep, og i monocytfunkjon.
FR2360311A1 (fr) Polysaccharide et ses applications pour le renforcement du debit cardiaque
DE68909245D1 (de) Übergangsmetall-stickstoffkomplex enthaltendes radiopharmazeutisches produkt mit einer neigung zum herzgewebe.
Kopera Lack of anticholinergic and cardiovascular effects of mianserin: Studies in healthy subjects and heart patients.
Thomas et al. Circulatory, psychological & performance variables during 100 hours of paced continuous exercise under conditions of controlled energy intake & work output.
Theye et al. The value of venous oxygen levels during general anesthesia
TWI263502B (en) Pharmaceutical preparation for treating ischemic disease of heart or limbs
Moreno The therapeutic role of the blues singer and considerations for the clinical applications of the blues form.
Landis et al. Automatic control for the artificial heart
HUT42940A (en) Process for production of medical preparative
EP0052085A3 (en) Pharmaceutical composition containing vincamine
SU1364313A1 (ru) Способ лечени острого инфаркта миокарда
JPS56108712A (en) Lecithin cholesterol acyl transferase activator